Wave Life Sciences (WVE) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to 0.52.
- Wave Life Sciences' Equity Ratio rose 3060.22% to 0.52 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52, marking a year-over-year increase of 3060.22%. This contributed to the annual value of 0.59 for FY2024, which is 31271.02% up from last year.
- As of Q3 2025, Wave Life Sciences' Equity Ratio stood at 0.52, which was up 3060.22% from 0.55 recorded in Q2 2025.
- Wave Life Sciences' 5-year Equity Ratio high stood at 0.6 for Q1 2025, and its period low was 0.31 during Q4 2022.
- Its 5-year average for Equity Ratio is 0.15, with a median of 0.14 in 2023.
- In the last 5 years, Wave Life Sciences' Equity Ratio tumbled by 4091357.7% in 2023 and then surged by 341433.52% in 2025.
- Over the past 5 years, Wave Life Sciences' Equity Ratio (Quarter) stood at 0.16 in 2021, then crashed by 296.21% to 0.31 in 2022, then skyrocketed by 146.79% to 0.14 in 2023, then surged by 312.71% to 0.59 in 2024, then fell by 13.26% to 0.52 in 2025.
- Its Equity Ratio was 0.52 in Q3 2025, compared to 0.55 in Q2 2025 and 0.6 in Q1 2025.